Associate Professor, Bioengineering, Stanford University
Jennifer is an Associate Professor in the Departments of Bioengineering and Chemical Engineering at Stanford University. She is currently the Director of Graduate Studies in Bioengineering and the Director of the Stanford Biotechnology Predoctoral Training Program. Jennifer received her PhD in Biological Chemistry at the Massachusetts Institute of Technology, where she also completed a postdoctoral fellowship in Biological Engineering. She has over 16 years of experience in protein-based drug discovery and development for applications in regenerative medicine and cancer therapy. Several of the technologies and therapeutics discovered in the Cochran laboratory are at various stages of commercialization and clinical translation, including protein therapeutics being developed as novel cancer medicines for broad patent populations.
Jennifer is currently on leave of absence from Stanford University to serve in a founding role of Chief Scientific Officer of Lagunita Biosciences, a healthcare investment company and incubator that creates and grows early stage companies to commercialize impactful translational science that addresses significant clinical needs. Favoring innovation over iteration, she encourages and helps guide Lagunita portfolio companies to develop technologies that push boundaries and are disruptive, and has served in various executive roles in these organizations.